ProText Mobility, Inc. (TXTM)
0.0099
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
ProText Mobility Enterprise Value : 87.23M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 87.23M |
| October 22, 2026 | 81.95M |
| October 21, 2026 | 81.07M |
| October 20, 2026 | 79.32M |
| October 19, 2026 | 79.32M |
| October 16, 2026 | 69.65M |
| October 15, 2026 | 52.94M |
| October 14, 2026 | 56.46M |
| October 13, 2026 | 61.38M |
| October 12, 2026 | 67.89M |
| October 09, 2026 | 65.25M |
| October 08, 2026 | 60.85M |
| October 07, 2026 | 61.73M |
| October 06, 2026 | 57.34M |
| October 05, 2026 | 52.06M |
| October 02, 2026 | 51.18M |
| October 01, 2026 | 46.79M |
| September 30, 2026 | 47.67M |
| September 29, 2026 | 45.03M |
| September 28, 2026 | 51.71M |
| September 25, 2026 | 31.84M |
| September 24, 2026 | 30.52M |
| September 23, 2026 | 31.40M |
| September 22, 2026 | 31.84M |
| September 21, 2026 | 31.84M |
| Date | Value |
|---|---|
| September 18, 2026 | 31.40M |
| September 17, 2026 | 30.96M |
| September 16, 2026 | 31.84M |
| September 15, 2026 | 30.96M |
| September 14, 2026 | 31.84M |
| September 11, 2026 | 31.84M |
| September 10, 2026 | 31.84M |
| September 09, 2026 | 31.84M |
| September 08, 2026 | 30.96M |
| September 04, 2026 | 30.96M |
| September 03, 2026 | 31.84M |
| September 02, 2026 | 30.96M |
| September 01, 2026 | 32.72M |
| August 31, 2026 | 33.60M |
| August 28, 2026 | 33.60M |
| August 27, 2026 | 35.36M |
| August 26, 2026 | 33.60M |
| August 25, 2026 | 34.48M |
| August 24, 2026 | 34.48M |
| August 21, 2026 | 32.28M |
| August 20, 2026 | 32.47M |
| August 19, 2026 | 34.92M |
| August 18, 2026 | 34.92M |
| August 17, 2026 | 32.28M |
| August 14, 2026 | 34.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 273.50M |
| Perspective Therapeutics, Inc. | -49.23M |
| Achieve Life Sciences, Inc. | 494.28M |
| MiMedx Group, Inc. | 451.15M |
| ABVC BioPharma, Inc. | 31.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0155M |
| Total Expenses (Quarterly) | 0.0155M |
| Earnings Yield | 1.01% |